Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 11Terminated 4Active not recruiting 2Withdrawn 1Unknown 1Suspended 1Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Nasopharyngeal Carcinoma 4Nasopharyngeal Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Oropharyngeal Neoplasms 2Carcinoma 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Nasopharyngeal Cancinoma (NPC) 1Mouth Neoplasms 1Lymphoma, Follicular 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Glioblastoma 1Esophageal Squamous Cell Carcinoma 1Carcinoma, Squamous Cell 1Carcinoma, Non-Small-Cell Lung 1Astrocytoma 1Advanced Glioblastoma 1

Interventions

Temozolomide 11Radiotherapy 4Magnetic Resonance Spectroscopy 4Specimen Handling 3Radiation 3Blood Specimen Collection 3Bevacizumab 3tislelizumab 2pembrolizumab 2Surgical Procedures, Operative 2mirdametinib 1gallium maltolate 1fluzoparib 1florbetapir 1elemene 1cemiplimab 1X-Rays 1Vortioxetine 1Transurethral Resection of Bladder 1Spironolactone 1Spinal Puncture 1Sitagliptin Phosphate 1Sampling Studies 1Receptors, Interleukin-8B 1Radiotherapy, Intensity-Modulated 1Psychosocial Intervention 1Platinum 1Photons 1Photochemotherapy 1Pharmaceutical Preparations 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Glioblastoma × Radiotherapy, Intensity-Modulated × Clear all
NCT04373785 2025-10-21

NG101m Adjuvant Therapy in Glioblastoma Patients

NeuGATE Theranostics

Phase 1/2 Not yet recruiting
52 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡